Best Practices for Launching Profitable, Efficient NGS Tests for Hereditary Risk

Next-generation sequencing (NGS) is gaining momentum, but implementing it well has its challenges 

The decreasing cost of implementing NGS has many clinical laboratories considering expanding the scope and complexity of their hereditary testing services to include NGS. However, this expansion comes with a significant number of challenges, including setup, panel design, and validation, building for optimum turnaround time, and the need for specialized clinical genetic knowledge and overall scalability. 

An effective strategy for selecting and implementing appropriate tertiary analysis tools and setting up a scalable interpretation workflow is critical to the success of a clinical NGS program.

The webinar, Best Practices for Launching Profitable, Efficient NGS Tests for Hereditary Risk, will discuss best practices for how molecular diagnostic labs can quickly and effectively launch NGS hereditary risk genetic testing, including: 

• Market trends and considerations
• Laboratory setup and validation, data analysis, and reporting
• Selecting and implementing a tertiary analysis pipeline for variant interpretation

Reserve your seat today for this practical, in-depth webinar on Wednesday, June 23, from 1-2:00 pm EDT.

Get expert guidance and best practices on how to successfully implement and scale NGS hereditary risk testing in your lab

As NGS instrumentation and technology have evolved, the accessibility of NGS has expanded for most laboratories. As a result, NGS is becoming a routine clinical practice in oncology and pathology. However, NGS is more complex than many commonly used testing methods, and practical bioinformatic analysis is crucial to process the massive amounts of data generated on each NGS run.

During this webinar, Fabric Genomics’ Charlene Son Rigby, MBA, Chief Business Officer, and Jeanette McCarthy, MPH, PhD, Sr. Director, Scientific Programs, along with Tootie Tatum, PhD,  Founder and CEO of Blackhawk Genomics, will increase attendees’ understanding of NGS workflow considerations, data interpretation and analysis, and best practices for implementation.

Learning objectives

By attending Best Practices for Launching Profitable, Efficient NGS Tests for Hereditary Risk, attendees will:

• Learn more about the market trends and revenue opportunities for clinical laboratories to perform hereditary NGS genetic tests
• Implement effective strategies to introduce NGS into the laboratory and overcome associated challenges, aligning capabilities and resources.
• Launch reimbursed genetic panels rapidly, implement in 4 weeks, and improve turnaround time (TAT)
• Learn how AI enables the growing community of laboratories to offer NGS tests effectively
• Use the best tools to scale interpretation workflow—critical to the success of a clinical NGS program
• Confidently, quickly, and successfully implement and scale NGS hereditary risk testing!

Who should attend?

• Clinical laboratory directors
• Laboratory managers
• Clinical pathologists
• Laboratory technicians
• Those new to NGS

Your registration includes:

• The opportunity to pose specific questions and connect directly with speakers during a Q&A session
• Access to the post-webinar recording

Hosted By